156 related articles for article (PubMed ID: 33364197)
1. A Novel Model Incorporating Tumor Stiffness, Blood Flow Characteristics, and Ki-67 Expression to Predict Responses After Neoadjuvant Chemotherapy in Breast Cancer.
Zhang J; Gao S; Zheng Q; Kang Y; Li J; Zhang S; Shang C; Tan X; Ren W; Ma Y
Front Oncol; 2020; 10():603574. PubMed ID: 33364197
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer.
Zhang J; Tan X; Zhang X; Kang Y; Li J; Ren W; Ma Y
Eur J Radiol; 2020 Aug; 129():109098. PubMed ID: 32559591
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer.
Zhang J; Zhang S; Gao S; Ma Y; Tan X; Kang Y; Ren W
Cancer Manag Res; 2020; 12():2209-2222. PubMed ID: 32273760
[TBL] [Abstract][Full Text] [Related]
4. Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
Ma Y; Zhang S; Zang L; Li J; Li J; Kang Y; Ren W
Eur J Cancer; 2016 Dec; 69():86-101. PubMed ID: 27821323
[TBL] [Abstract][Full Text] [Related]
5. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers.
Ma Y; Zhang S; Li J; Li J; Kang Y; Ren W
Eur Radiol; 2017 Jun; 27(6):2282-2291. PubMed ID: 27752835
[TBL] [Abstract][Full Text] [Related]
6. Potential value of tumor stiffness and sE-cadherin in predicting the response to neoadjuvant therapy in HER2-positive breast cancers.
Zhou W; Wu M; Lin H; Chen W; Lu G; Yang F; Chen Y; Chen G
Future Oncol; 2022 Aug; 18(25):2817-2825. PubMed ID: 35730465
[TBL] [Abstract][Full Text] [Related]
7. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer.
Gu J; Polley EC; Denis M; Carter JM; Pruthi S; Gregory AV; Boughey JC; Fazzio RT; Fatemi M; Alizad A
Breast Cancer Res; 2021 Apr; 23(1):52. PubMed ID: 33926522
[TBL] [Abstract][Full Text] [Related]
8. Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI.
Evans A; Whelehan P; Thompson A; Purdie C; Jordan L; Macaskill J; Henderson S; Vinnicombe S
Clin Radiol; 2018 Oct; 73(10):910.e1-910.e6. PubMed ID: 29980324
[TBL] [Abstract][Full Text] [Related]
9. Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer After the Second Cycle of Chemotherapy Using Shear-Wave Elastography-A Preliminary Evaluation.
Singh T; Kumar N; Sandhu M; Singla V; Singh G; Bal A
Ultrasound Q; 2021 Mar; 37(1):16-22. PubMed ID: 33661797
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of change in tumor stiffness measured by acoustic radiation force impulse imaging for early prediction of response to neoadjuvant chemotherapy in breast cancer.
Mahadevan GSV; Chakkalakkoombil SV; Kayal S; Dharanipragada K; Toi PC; Ananthakrishnan R
J Clin Ultrasound; 2022 Jun; 50(5):666-674. PubMed ID: 35353384
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
Conz L; Jales RM; Dória MT; Melloni I; Cres Lyrio CA; Menossi C; Derchain S; Sarian LO
PLoS One; 2024; 19(6):e0302527. PubMed ID: 38833499
[TBL] [Abstract][Full Text] [Related]
12. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?
Dave S; Choudhury A; Alurkar SS; Shah AM
Indian J Surg Oncol; 2024 Mar; 15(1):44-52. PubMed ID: 38511030
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
[TBL] [Abstract][Full Text] [Related]
14. Early Evaluation of Relative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Jing H; Cheng W; Li ZY; Ying L; Wang QC; Wu T; Tian JW
J Ultrasound Med; 2016 Aug; 35(8):1619-27. PubMed ID: 27302898
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?
Gu JH; He C; Zhao QY; Jiang TA
Breast Cancer; 2022 May; 29(3):478-486. PubMed ID: 35038129
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Jain P; Doval DC; Batra U; Goyal P; Bothra SJ; Agarwal C; Choudhary DK; Yadav A; Koyalla VPB; Sharma M; Dash P; Talwar V
Jpn J Clin Oncol; 2019 Apr; 49(4):329-338. PubMed ID: 30753543
[TBL] [Abstract][Full Text] [Related]
17. [The application of 3-dimensional shear wave elastography in the therapeutic effect evaluation of neoadjuvant chemotherapy for Her-2 positive breast cancer patients].
Ma BX; Fan ZN; Wu G
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1049-1054. PubMed ID: 33342163
[No Abstract] [Full Text] [Related]
18. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Chatterjee D; Bal A; Das A; Singh G
Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
[TBL] [Abstract][Full Text] [Related]
19. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
Pesapane F; Rotili A; Botta F; Raimondi S; Bianchini L; Corso F; Ferrari F; Penco S; Nicosia L; Bozzini A; Pizzamiglio M; Origgi D; Cremonesi M; Cassano E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503081
[TBL] [Abstract][Full Text] [Related]
20. Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study.
Tang L; Shu X; Tu G
World J Surg Oncol; 2022 Jan; 20(1):27. PubMed ID: 35093083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
